enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Biocon - Wikipedia

    en.wikipedia.org/wiki/Biocon

    Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India.It was founded by Kiran Mazumdar-Shaw in 1978. [4] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [5] including the United States and Europe. [4]

  3. Viatris - Wikipedia

    en.wikipedia.org/wiki/Viatris

    In February 2022, Viatris announced an agreement where it will contribute to Biocon Biologics its biosimilars portfolio and related commercial and operational capabilities in exchange for up to $3.335 billion, including a stake of at least 12.9% in Biocon Biologics. [11] The transaction was completed in November 2022. [12]

  4. Kiran Mazumdar-Shaw - Wikipedia

    en.wikipedia.org/wiki/Kiran_Mazumdar-Shaw

    Kiran Mazumdar-Shaw (born 23 March 1953) is an Indian billionaire entrepreneur. [3] She is the executive chairperson and founder of Biocon Limited and Biocon Biologics Limited, [4] a biotechnology company based in Bangalore, India [5] and the former chairperson of Indian Institute of Management, Bangalore. [6]

  5. India's Biocon posts Q1 profit rise on sale of branded ... - AOL

    www.aol.com/news/indias-biocon-posts-q1-profit...

    Biopharmaceutical company Biocon Ltd reported a more than six-fold rise in first-quarter profit on Thursday, boosted by a one-time gain from the sale of its Indian branded formulations business.

  6. Biotechnology in India - Wikipedia

    en.wikipedia.org/wiki/Biotechnology_in_India

    The first Indian biotechnology company to be established was Biocon, which was founded by Kiran Mazumdar-Shaw in 1978. [3] The Indian biotechnology industry formally began in 1986 with the establishment of the Department of Biotechnology (DBT) by the Ministry of Science and Technology. [4]

  7. India's Biocon Biologics launches biosimilar for AbbVie's ...

    www.aol.com/news/indias-biocon-biologics...

    The launch of the copycat version, branded as Hulio, adds to a list of biosimilars introduced by drugmakers on Monday by Coherus Biosciences and Germany's Fresenius. Boehringer Ingelheim and Swiss ...

  8. Kevin W. Warsh - Pay Pals - The Huffington Post

    data.huffingtonpost.com/paypals/kevin-w-warsh

    From July 2012 to December 2012, if you bought shares in companies when Kevin W. Warsh joined the board, and sold them when he left, you would have a -1.5 percent return on your investment, compared to a 4.9 percent return from the S&P 500.

  9. Sharon L. Allen - Pay Pals - The Huffington Post

    data.huffingtonpost.com/paypals/sharon-l-allen

    From August 2012 to December 2012, if you bought shares in companies when Sharon L. Allen joined the board, and sold them when she left, you would have a 60.8 percent return on your investment, compared to a 3.7 percent return from the S&P 500.